Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HEG8
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016553 | base conversion or substitution editing | 6 | 1 |
GO:0016554 | cytidine to uridine editing | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 198 | 202 | PF00656 | 0.584 |
CLV_C14_Caspase3-7 | 89 | 93 | PF00656 | 0.606 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.454 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.548 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.624 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.508 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.610 |
CLV_NRD_NRD_1 | 233 | 235 | PF00675 | 0.639 |
CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.648 |
CLV_NRD_NRD_1 | 278 | 280 | PF00675 | 0.631 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.636 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.645 |
CLV_PCSK_KEX2_1 | 207 | 209 | PF00082 | 0.550 |
CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.610 |
CLV_PCSK_KEX2_1 | 233 | 235 | PF00082 | 0.639 |
CLV_PCSK_KEX2_1 | 268 | 270 | PF00082 | 0.644 |
CLV_PCSK_KEX2_1 | 278 | 280 | PF00082 | 0.639 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.636 |
CLV_PCSK_PC7_1 | 188 | 194 | PF00082 | 0.560 |
CLV_PCSK_PC7_1 | 203 | 209 | PF00082 | 0.542 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.513 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.468 |
CLV_PCSK_SKI1_1 | 155 | 159 | PF00082 | 0.414 |
DOC_MAPK_gen_1 | 154 | 162 | PF00069 | 0.353 |
DOC_MAPK_gen_1 | 188 | 197 | PF00069 | 0.558 |
DOC_USP7_MATH_1 | 209 | 213 | PF00917 | 0.555 |
DOC_USP7_MATH_1 | 239 | 243 | PF00917 | 0.663 |
DOC_USP7_MATH_1 | 300 | 304 | PF00917 | 0.622 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.528 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.665 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.620 |
LIG_14-3-3_CanoR_1 | 188 | 192 | PF00244 | 0.549 |
LIG_14-3-3_CanoR_1 | 2 | 7 | PF00244 | 0.512 |
LIG_14-3-3_CanoR_1 | 288 | 295 | PF00244 | 0.581 |
LIG_14-3-3_CanoR_1 | 304 | 309 | PF00244 | 0.596 |
LIG_14-3-3_CanoR_1 | 42 | 49 | PF00244 | 0.626 |
LIG_FHA_1 | 109 | 115 | PF00498 | 0.478 |
LIG_FHA_1 | 120 | 126 | PF00498 | 0.414 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.528 |
LIG_FHA_2 | 271 | 277 | PF00498 | 0.538 |
LIG_LIR_Gen_1 | 127 | 136 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.494 |
LIG_PCNA_PIPBox_1 | 110 | 119 | PF02747 | 0.347 |
LIG_SH2_SRC | 170 | 173 | PF00017 | 0.465 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.403 |
LIG_SH3_1 | 246 | 252 | PF00018 | 0.504 |
LIG_SH3_3 | 241 | 247 | PF00018 | 0.670 |
LIG_SH3_3 | 72 | 78 | PF00018 | 0.608 |
LIG_SUMO_SIM_par_1 | 121 | 127 | PF11976 | 0.356 |
LIG_WW_1 | 251 | 254 | PF00397 | 0.582 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.442 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.530 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.681 |
MOD_CK1_1 | 35 | 41 | PF00069 | 0.506 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.703 |
MOD_CK1_1 | 50 | 56 | PF00069 | 0.709 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.594 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.464 |
MOD_Cter_Amidation | 266 | 269 | PF01082 | 0.702 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.440 |
MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.587 |
MOD_GlcNHglycan | 241 | 244 | PF01048 | 0.698 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.618 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.457 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.742 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.568 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.424 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.680 |
MOD_GSK3_1 | 209 | 216 | PF00069 | 0.530 |
MOD_GSK3_1 | 235 | 242 | PF00069 | 0.636 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.535 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.812 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.603 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.552 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.565 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.557 |
MOD_N-GLC_1 | 255 | 260 | PF02516 | 0.550 |
MOD_N-GLC_1 | 284 | 289 | PF02516 | 0.668 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.525 |
MOD_N-GLC_1 | 87 | 92 | PF02516 | 0.579 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.501 |
MOD_NEK2_2 | 121 | 126 | PF00069 | 0.439 |
MOD_PIKK_1 | 270 | 276 | PF00454 | 0.540 |
MOD_PK_1 | 104 | 110 | PF00069 | 0.421 |
MOD_PKA_1 | 213 | 219 | PF00069 | 0.539 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.457 |
MOD_PKA_2 | 187 | 193 | PF00069 | 0.554 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.539 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.653 |
MOD_Plk_1 | 104 | 110 | PF00069 | 0.480 |
MOD_Plk_1 | 60 | 66 | PF00069 | 0.539 |
MOD_Plk_1 | 93 | 99 | PF00069 | 0.451 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.447 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.409 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.666 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.621 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.504 |
TRG_ER_diArg_1 | 147 | 149 | PF00400 | 0.367 |
TRG_ER_diArg_1 | 191 | 193 | PF00400 | 0.664 |
TRG_ER_diArg_1 | 207 | 209 | PF00400 | 0.593 |
TRG_ER_diArg_1 | 233 | 235 | PF00400 | 0.606 |
TRG_ER_diArg_1 | 295 | 297 | PF00400 | 0.689 |
TRG_Pf-PMV_PEXEL_1 | 149 | 153 | PF00026 | 0.345 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1H0 | Leptomonas seymouri | 43% | 97% |
A0A3S7WZ80 | Leishmania donovani | 70% | 100% |
A4I1M2 | Leishmania infantum | 70% | 100% |
E9AXQ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 100% |
Q4Q9R5 | Leishmania major | 71% | 97% |